DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
San Francisco, CA
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Redmile Growth Investments I, L.P. | 2021 | Mature | $122M | $157M | 0 |
| Redmile Biopharma Investments III, LP | 2020 | Mature | $500M | $1.2B | 0 |
| Redmile Biopharma Investments II, L.P. | 2019 | Mature | $675M | $828M | 0 |
| RAF, L.P. | 2018 | Harvest | n/a | $261M | 0 |
| Redmile Biotechnologies Investments I Af, L.P. | 2015 | Harvest | $218M | $143M | 0 |
| Redmile Private Investments II, L.P. | 2015 | Harvest | $131M | $61.6M | 0 |
| Redmile Private Investments I Affiliates, LP | 2014 | Harvest | $28.7M | $11.9M | 0 |
| Redmile Private Investments I, L.P. | 2013 | Harvest | $0 | $15.9M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Clearlabs | n/a | n/a | n/a | n/a | Unknown | Sep 18, 2026 |
| Ambrosia Biosciences Inc. | Co | Series b | $100M | n/a | Unknown | Mar 31, 2026 |
| Bambusa Therapeutics, Inc. | Ma | Series a | n/a | n/a | Unknown | Nov 17, 2025 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Deep Track Capital | Redmile Group | 1 | 1 | Mar 31, 2026 | One time |
| Redmile Group | Ince Capital Ltd. | 1 | 1 | Nov 17, 2025 | One time |
| Redmile Group | BVF Partners L | 1 | 1 | Nov 17, 2025 | One time |
| Redmile Group | RA Capital Management, LP | 1 | 1 | Nov 17, 2025 | One time |
| Menlo Ventures | Redmile Group | 1 | 1 | Sep 18, 2026 | One time |
| Addition, L.P. | Redmile Group | 1 | 1 | Sep 18, 2026 | One time |
| Khosla Ventures, LLC | Redmile Group | 1 | 1 | Sep 18, 2026 | One time |
| Morgan Stanley | Redmile Group | 1 | 1 | Sep 18, 2026 | One time |
| Wing VC | Redmile Group | 1 | 1 | Sep 18, 2026 | One time |
| BVF Partners | Redmile Group | 1 | 1 | Mar 31, 2026 | One time |
| ATHOS KG | Redmile Group | 1 | 1 | Nov 17, 2025 | One time |
| Samsara Biocapital, LLC | Redmile Group | 1 | 1 | Mar 31, 2026 | One time |
| Boulder Ventures | Redmile Group | 1 | 1 | Mar 31, 2026 | One time |
| Blue Owl Healthcare Opportunities | Redmile Group | 1 | 1 | Mar 31, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Bryan Ranney Crapo (Chief Operating Officer), Michael Stewart Lee (Managing Director), Robert Carrington Faulkner (Managing Director), Amrit Nmn Nagpal (Managing Director), Jennifer Kate Ciresi (General Counsel And Chief Compliance Officer), Owen John Leary (Managing Director), Jeremy Charles Green (Managing Member), Josh Garcia (Chief Financial Officer).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan